e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary vascular diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
B. Boerrigter, H. Rietema, H. Groepenhoff, P. Postmus, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
Source:
Annual Congress 2010 - Pulmonary vascular diseases
Session:
Pulmonary vascular diseases
Session type:
Thematic Poster Session
Number:
4477
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Boerrigter, H. Rietema, H. Groepenhoff, P. Postmus, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands). Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 4477
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
Cardiac response to exercise in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
Exercise heart rate recovery in chronic obstructive pulmonary disease patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
The assessment of exercise capacity in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Increased arterial stiffness in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 65s
Year: 2006
Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept